A
Akebia Therapeutics, Inc.
AKBA · NASDAQ · Healthcare · 234M
Closing price
$0.80
-1.68% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
6.3×
Enterprise value / EBITDAEV/EBITDA
10.9×
Free cash flow yieldFCF yield
33.0%
Return on equityROE
-16.4%
Operating margin
9.9%
Net debt / EBITDAbalance-sheet strength
1.4×
Interest coverage
1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.